HIMZ vs. PJP

Last updated Jun 23, 2026

HIMZ (Defiance Daily Target 2X Long HIMS ETF) and PJP (Invesco Dynamic Pharmaceuticals ETF) are both exchange-traded funds - HIMZ is a Leveraged Equities fund actively managed by Defiance, while PJP is a Health & Biotech Equities fund tracking the Dynamic Pharmaceuticals Intellidex Index. HIMZ is actively managed, while PJP is passively managed. Over the past year, HIMZ returned -93.28% vs 42.28% for PJP. At a 0.20 correlation, their price movements are largely independent. HIMZ charges 1.31%/yr vs 0.58%/yr for PJP.

Performance

HIMZ vs. PJP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Daily Target 2X Long HIMS ETF (HIMZ) and Invesco Dynamic Pharmaceuticals ETF (PJP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HIMZ achieves a -42.46% return, which is significantly lower than PJP's 7.87% return.

HIMZ

• 1D: -10.79%
• 1M: 84.86%
• YTD: -42.46%
• 6M: -51.22%
• 1Y: -93.28%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PJP

• 1D: 0.70%
• 1M: 3.08%
• YTD: 7.87%
• 6M: 4.83%
• 1Y: 42.28%
• 3Y*: 15.13%
• 5Y*: 8.22%
• 10Y*: 7.25%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HIMZ vs. PJP - Yearly Performance Comparison

	2026 (YTD)	2025
HIMZ Defiance Daily Target 2X Long HIMS ETF	-42.46%	-69.65%
PJP Invesco Dynamic Pharmaceuticals ETF	7.87%	25.14%

Correlation

The correlation between HIMZ and PJP is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (All Time) Calculated using the full available price history since Mar 13, 2025	0.20

HIMZ vs. PJP - Sectors Allocation Comparison

Sectors	HIMZ	PJP
Consumer Defensive	100.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Energy	-	-
Financial Services	-	0.0%
Healthcare	-	100.0%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

HIMZ vs. PJP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMZ

HIMZ Risk / Return Rank: 4
HIMZ Sharpe Ratio Rank: 5
HIMZ Sortino Ratio Rank: 5
HIMZ Omega Ratio Rank: 5
HIMZ Calmar Ratio Rank: 1
HIMZ Martin Ratio Rank: 3

PJP

PJP Risk / Return Rank: 81
PJP Sharpe Ratio Rank: 84
PJP Sortino Ratio Rank: 85
PJP Omega Ratio Rank: 76
PJP Calmar Ratio Rank: 85
PJP Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIMZ vs. PJP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Daily Target 2X Long HIMS ETF (HIMZ) and Invesco Dynamic Pharmaceuticals ETF (PJP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HIMZ	PJP	Difference
Sharpe ratio: Return per unit of total volatility	-0.48	2.57	-3.05
Sortino ratio: Return per unit of downside risk	-0.51	3.62	-4.13
Omega ratio: Gain probability vs. loss probability	0.94	1.43	-0.49
Calmar ratio: Return relative to maximum drawdown	-0.96	4.50	-5.46
Martin ratio: Return relative to average drawdown	-1.25	14.26	-15.52

HIMZ vs. PJP - Sharpe Ratio Comparison

The current HIMZ Sharpe Ratio is -0.48, which is lower than the PJP Sharpe Ratio of 2.57. The chart below compares the historical Sharpe Ratios of HIMZ and PJP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HIMZ vs. PJP - Drawdown Comparison

The maximum HIMZ drawdown since its inception was -98.18%, which is greater than PJP's maximum drawdown of -37.06%. Use the drawdown chart below to compare losses from any high point for HIMZ and PJP.

Drawdown Indicators

	HIMZ	PJP	Difference
Max Drawdown Largest peak-to-trough decline	-98.18%	-37.06%	-61.12%
Max Drawdown (1Y) Largest decline over 1 year	-97.18%	-9.44%	-87.74%
Max Drawdown (3Y) Largest decline over 3 years	—	-16.27%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-17.51%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-33.95%	—
Current Drawdown Current decline from peak	-93.75%	-1.26%	-92.49%
Average Drawdown Average peak-to-trough decline	-69.71%	-8.83%	-60.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	81.79%	2.97%	+78.82%

Volatility

HIMZ vs. PJP - Volatility Comparison

Defiance Daily Target 2X Long HIMS ETF (HIMZ) has a higher volatility of 46.24% compared to Invesco Dynamic Pharmaceuticals ETF (PJP) at 5.20%. This indicates that HIMZ's price experiences larger fluctuations and is considered to be riskier than PJP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HIMZ	PJP	Difference
Volatility (1M) Calculated over the trailing 1-month period	46.24%	5.20%	+41.04%
Volatility (6M) Calculated over the trailing 6-month period	136.23%	12.34%	+123.89%
Volatility (1Y) Calculated over the trailing 1-year period	195.42%	16.54%	+178.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	200.59%	16.19%	+184.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	200.59%	18.39%	+182.20%

HIMZ vs. PJP - Expense Ratio Comparison

HIMZ has a 1.31% expense ratio, which is higher than PJP's 0.58% expense ratio.

Dividends

HIMZ vs. PJP - Dividend Comparison

HIMZ's dividend yield for the trailing twelve months is around 4.25%, more than PJP's 1.19% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HIMZ Defiance Daily Target 2X Long HIMS ETF	4.25%	2.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PJP Invesco Dynamic Pharmaceuticals ETF	0.95%	0.98%	0.97%	1.01%	0.95%	0.81%	0.75%	0.77%	1.12%	0.65%	0.91%	5.49%

Frequently Asked Questions

Can I hold both HIMZ and PJP in my portfolio?

HIMZ and PJP have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HIMZ or PJP?

HIMZ has higher volatility (46.24%) compared to PJP (5.20%). In terms of maximum drawdown, HIMZ dropped -98.18% vs PJP's -37.06%.

Which ETF is better, HIMZ or PJP?

On 1-year performance, PJP leads with 42.28% vs -93.28% for HIMZ. On fees, PJP is cheaper at 0.58% per year. On volatility, PJP has been the lower-risk option at 5.20%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, HIMZ or PJP?

Over the 1-year period, PJP has performed better with a 42.28% return vs -93.28%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, HIMZ or PJP?

PJP is cheaper with a 0.58% expense ratio, compared with 1.31% for HIMZ.

Which ETF pays a higher dividend yield, HIMZ or PJP?

HIMZ has the higher dividend yield at 4.25%, compared with 1.19% for PJP.

What is the main difference between HIMZ and PJP?

HIMZ is categorized as Leveraged Equities, while PJP is Health & Biotech Equities. They also come from different issuers: Defiance and Invesco. Their fees differ too: 1.31% for HIMZ and 0.58% for PJP.

Which has better risk-adjusted returns?

PJP currently has the higher Sharpe Ratio (2.57 vs -0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.